(Stroke. 1995;26:1293-1301.)
© 1995 American Heart Association, Inc.
Articles |
The Significance of Cerebral White Matter Abnormalities 100 Years After Binswanger's Report
A Review
From the Department of Pathology (Neuropathology), Henry Ford Hospital, Detroit, Mich (L.P., J.H.G.); the Department of Pathology (Neuropathology), Case Western Reserve University, Cleveland, Ohio (J.H.G.); and the Department of Neurological and Psychiatric Sciences, University of Florence (Italy) (L.P.).
Correspondence to Julio H. Garcia, MD, Department of Pathology (Neuropathology), Henry Ford Hospital, K-6, 2799 W Grand Blvd, Detroit, MI 48202-2689.
 |
Abstract |
|---|
 Top Abstract IntroductionHistorical OverviewLeukoaraiosisConclusionsReferences |
|---|
Background Changes in the cerebral hemispheric white matter are detected with increasing frequency by CT and MRI among persons older than 60 years. The pathogenesis, clinical significance, and morphological substrate of these changes are incompletely understood. Patients who have such neuroimaging abnormalities are sometimes diagnosed with "Binswanger's disease," an eponym that has generated much confusion because of its imprecise meaning. The objectives of this study were to determine whether the term Binswanger's disease merits acceptance as a distinct clinicopathologic entity, to deduce the clinical significance of these white matter abnormalities from the analysis of appropriate publications, and to evaluate studies that correlate in vivo changes in the cerebral white matter with pathological features.
Summary of Review We evaluated Binswanger's original case description and, after conducting a Medline search, reviewed more than 160 publications, mostly in the English language, on the subject of white matter abnormalities detectable by currently used neuroimaging methods (ie, leukoaraiosis).
Conclusions Binswanger's original description appears to be insufficient for the purpose of defining a new nosological entity. After evaluating the vaguely outlined pathological correlates described in a few of these subcortical cerebral leukoencephalopathies, we conclude that the clinical significance of leukoaraiosis remains incompletely defined. However, its frequency increases with age independent of other risk factors, and in nondemented subjects leukoaraiosis is associated with deficits in selected cognitive functions. Moreover, leukoaraiosis correlates with an increased risk for the subsequent development of strokes. We make specific suggestions for future studies that may help to clarify this topic.
Key Words: leukoencephalopathy • small-vessel disease • leukoaraiosis • dementia
|
Introduction |
|---|
|
TopAbstractIntroductionHistorical OverviewLeukoaraiosisConclusionsReferences |
|---|
The application of CT in the 1970s and the subsequent application of MRI to image the intracranial contents have revealed an unexpected number of changes in the cerebral white matter of both asymptomatic and cognitively impaired individuals.
The pathogenesis, clinical significance, and pathological substrate of these white matter alterations are incompletely understood. Even the optimal term to designate these changes is controversial; some authors assume that the cerebral white matter changes (demonstrated by CT or MRI) are synonymous with "Binswanger's disease" (an eponym of nebulous meaning), while others use the term leukoaraiosis to refer to all white matter changes visible on neuroimaging studies.
We reviewed a selected number of publications, most of which appeared after 1979, for the purpose of (1) determining whether the term Binswanger's disease merits its acceptance as a distinct clinicopathologic entity, (2) summarizing a large and controversial number of publications dealing with the clinical relevance of white matter abnormalities detected by either CT or MRI, and (3) evaluating studies based on the correlation observed between in vivo observations and histopathological analysis of cerebral white matter.
|
Historical Overview |
|---|
|
TopAbstractIntroductionHistorical OverviewLeukoaraiosisConclusionsReferences |
|---|
In 1894, in a lengthy manuscript dealing with the differential diagnosis of general paresis of the insane, Otto Binswanger described the case of a syphilitic man in his mid-fifties who had developed a progressive decline in mental functions characterized by speech and memory disorders, depression, and personality changes, accompanied by diminished motor power in the lower extremities and slight hand tremor.1 2 At autopsy, the dura mater at the base of the skull showed granular deposits; there was also minimal intracranial atherosclerosis, considerable enlargement of the lateral ventricles, marked atrophy of the cerebral white matter, and multiple ependymal thickenings.1 2
Binswanger neither provided microscopic descriptions nor illustrated any findings of this single case; an additional seven cases were mentioned in a footnote, but these cases were never further described. In subsequent publications Binswanger did not deal again with the topic of white matter disease, and in fact he did not attribute much significance to the case included in his 1894 report.3 In 1902 Alzheimer,4 5 referring to the case described by his mentor Otto Binswanger, added a short histological description of what he considered was an analogous case and intuitively attributed the white matter changes to arteriosclerosis of the long penetrating vessels. In 1962 J. Olszewski,6 after careful review of Binswanger's original report, suggested that the lesions in the dura mater and in the ependyma, together with the history of syphilis, made Binswanger's a likely case of neurosyphilis; accordingly, he proposed the term subcortical arteriosclerotic encephalopathy to describe "a form of cerebral arteriosclerosis in which vessels of the white matter and subcortical grey matter are affected predominantly."6 Significantly, as of 1987 when Babikian and Ropper7 wrote a review, the pathological diagnosis of this obscure entity (Binswanger's disease or subcortical arteriosclerotic encephalopathy) was limited to fewer than 50 cases.
Contemporaneously, the diagnosis of Binswanger's disease (ie, cerebral white matter abnormalities) had acquired new popularity after the introduction of CT and its first diagnosis based on clinical and CT findings.8 The increasing availability of CT and MRI led many to assume that Binswanger's disease could be diagnosed premortem.9 10 11 12 13 14 15 However, it soon became apparent that alterations of the hemispheric white matter (detected by either CT or MRI) were common in both symptomatic and asymptomatic subjects. Román16 17 suggested that among asymptomatic individuals, the white matter abnormalities seen on CT or MRI might represent an early form of Binswanger's disease.
Today it seems impossible to determine with certainty the nature of the disease affecting the patient vaguely described by Binswanger, but it seems reasonable to conclude that Binswanger's description cannot be applied to what was later considered a form of dementia secondary to cerebral atherosclerosis.16 Moreover, it may be futile to label patients showing radiological white matter abnormalities of unknown origin as having a disease for which definite clinical or pathological criteria do not exist. For these reasons we suggest that the eponym Binswanger's disease lacks medical significance or relevance.
|
Leukoaraiosis |
|---|
|
TopAbstractIntroductionHistorical OverviewLeukoaraiosisConclusionsReferences |
|---|
Definition
In an attempt to overcome the tendency to identify a neuroimaging abnormality with a vaguely defined disease process, Hachinski et al18 19 introduced the term leukoaraiosis (from the Greek leuko [white] and araiosis [rarefaction]) to designate periventricular or subcortical (centrum semiovale) areas of hypodensity on CT or hyperintensity on T2-weighted MRI whose origin deserves further elucidation. The term leukoaraiosis (LA) refers to both the CT- and MRI-detectable alterations, although the lesions are not completely superimposable as to number, site, and extension.20 21 22 23 24 25 26 27 Also, some authors suggest that MRI can detect LA at an earlier stage than CT.28 For these reasons, in this review we discuss LA as seen separately on CT and MRI.
Frequency
LA is frequently detected by CT and MRI both in asymptomatic
persons older than 60 years and in cognitively impaired individuals,
especially those who have evidence of either cerebrovascular disease or
risk factors associated with stroke.29 Among patients with
dementia of presumed vascular origin (VaD), LA is detected by CT in
41% to 100%20 30 31 32 33 34 35 36 37 38 39 and by MRI in 64% to 100% of the
cases.20 30 40 41 42 43 44 45 46 47 This increased frequency of LA among
patients who have risk factors associated with vascular disease is one
of the clues suggesting a possible ischemic pathogenesis for
LA. Thus, it is intriguing that a large proportion of
Alzheimer's disease (AD) patients (ranging from 19% to 78%
in CT-based studies20 30 31 32 33 34 35 38 39 48 49 50 51 52 53 54 55 and from 7.5% to
100% in MRI studies20 22 30 40 42 43 44 45 47 52 56 57 58 59 60 ) have
LA, although usually the changes in white matter density are less
severe in AD patients than in those with cerebrovascular
disorders.40 42 44 47 48 61 White matter abnormalities in
patients with AD, according to some authors, might be associated with
cerebral congophilic angiopathy, one of the microscopic hallmarks of
AD.62 63
LA in normal control subjects is usually less severe than in demented patients,45 57 64 yet LA is detected in up to 21% of asymptomatic subjects evaluated with CT30 31 32 39 49 50 52 65 and in up to 100% among those evaluated with MRI.22 27 30 40 42 43 44 45 52 56 57 60 61 66 67 68 69 70 71 72 73 74 75 Inference on the prevalence of LA in the normal population cannot be deduced from these investigations because the definition of normal subjects varies in each study. Two recent population-based studies76 77 reported MRI-detectable LA (MRI-LA) in 27% and 38% of subjects with a mean age greater than 65.
A wide discrepancy exists among reports dealing with the frequency of LA. This can be attributed to the inclusion of subjects with different ages, variably associated cerebrovascular risk factors and, in MRI studies, application of diverse strengths of magnetic field and variations in pulse sequence, as well as on different definitions of MRI-LA. A frequently used classification separates MRI-LA into periventricular and deep subcortical lesions and grades each according to its severity.40 Periventricular MRI-LA is detected more frequently than deep subcortical (centrum semiovale) MRI-LA; however, not all authors considered these lesions separately.22 25 61 78 79 80
Effect of Aging and Cerebrovascular Risk Factors
Both the frequency and the severity of CT-detectable LA
(CT-LA) and MRI-LA increase with aging, as reported in patients with
diverse diseases,15 25 30 44 56 72 78 79 80 81 82 83 84 85 86 87 88 89 90 in normal
volunteers,22 49 56 61 68 69 70 71 73 74 75 76 82 83 90 91 92 93 94 95 and in two
population-based studies.77 93 Only a minority of studies
found a lack of correlation between aging and either the presence or
severity of MRI-LA.41 44 71 96 With the exception of one
CT-based study,32 the association between LA and aging
exists independent of the increased presence of vascular risk factors
in persons older than 60 years
(Table
).47 76 82 84 87 95 97 98 99
|
Arterial hypertension is commonly associated with changes in the white
matter detectable by CT. This association exists in patients with
cerebrovascular accidents and dementia35 50 54 81 100 101
as well as in asymptomatic control subjects.49 The
exclusion of patients with chronic hypertension from the diagnosis of
AD may explain why in some studies there was no increased frequency of
hypertension among AD patients with CT-LA.49 51 81
However, when the importance of history of stroke and of hypertension
are contemporaneously evaluated, the former becomes
equal97 to or more important32 99 than
hypertension as a predictor of LA (Table
). Evidence of CT-LA, in
particular, correlates with lacunar infarcts97 and
intracerebral hemorrhage,102 two entities
that have a close association with arterial hypertension. It seems
surprising that one study reported an association between CT-LA and a
systolic blood pressure lower than 130 mm Hg, together with evidence
of heart failure.39 Probably this is because hypertension
plays a fundamental role in the development of early changes affecting
the long penetrating arteries of the white matter.103
After arteriolosclerotic changes such as hyalinization begin to affect
many cerebral blood vessels, transient decreases in cerebral blood flow
(as elicited by cardiac dysrhythmia, improper administration of
antihypertensive therapy, or failure of autoregulatory mechanisms, as
recently demonstrated in patients with CT-LA104 ) could
lead to ischemic injury of the periventricular white matter.
The periventricular white matter corresponds to a terminal field, and
this could make it selectively vulnerable to changes in blood
pressure.105 The fact that the degree of carotid stenosis
does not influence the severity of LA99 indirectly
supports the view that LA is closely linked to disease of small
arteries and arterioles.
An association between LA and risk factors for cerebrovascular
disease has been shown repeatedly by MRI-based
studies.15 26 27 44 56 66 70 74 75 78 79 80 85 88 106 107 The
application of multivariate analysis does not provide concordant
results among all the studies reviewed (Table); nevertheless, it
appears reasonable that risk factors associated with cerebrovascular
disease may worsen a process such as LA, which is sensitively
influenced by aging.
Cognitive Impairment
Few topics in neurology are as controversial as the issue of
whether LA may influence the severity of cognitive impairment among
demented patients or the cognitive prowess of otherwise normal
subjects.
A correlation between cognitive impairment and the presence or severity of CT or MRI-LA has been inconsistently reported in AD patients40 43 45 53 55 56 59 96 108 and in studies that failed to specify the type of demented patients included.21 30 42 61 88 Among patients with dementia of presumed vascular origin, only the severity of LA (graded on MR images46 106 109 ) rather than its presence (on CT32 110 ) correlates with the degree of dementia.
Although seeking cognitive abnormalities in normal subjects with LA might appear tautological, a few studies have shown that CT-LA111 or MRI-LA43 67 68 69 107 does not significantly influence the general cognitive profile of normal volunteers.
Because aging as well as other associated factors may influence cognitive performances, the use of multivariate analyses is essential in this evaluation. After controlling for the possible confounding effects of age, sex, level of education, and the neuroimaging evidence of brain infarcts, CT-LA correlates with low neuropsychological scores in nondemented subjects.65 Among cognitively impaired patients, CT-LA is not associated with the diagnosis of dementia32 ; however, these patients show a trend toward low cognitive performance with respect to demented patients without CT-LA.48 In contrast, multivariate analysis results based on MRI data partially deny that LA would affect cognition in nondemented patients84 or in normal subjects.69 74 75 One possible explanation for the disparity in the results obtained by CT- and MRI-based studies is that MRI tends to detect a larger number of milder lesions than CT, and it is therefore less specific. In fact, a significant difference in cognitive and neurobehavioral functions is found when normal volunteers with a marked degree of MRI-LA are compared with those without LA.93 94 Quantitating the severity of MRI-LA may be necessary in future studies. A threshold exists between the extent of MRI-LA and subtle cognitive impairment; among 100 volunteers participating in a single study, those in whom MRI-LA involved an area greater than 10 cm2 had significant decreases in cognitive performances involving frontal lobe abilities, attention, and speed of information processing.73 An added possible cause of inconsistency among various studies may derive from the application of neuropsychological tests that are acceptable for screening purposes but are inadequate to detect subtle or specific cognitive functional changes; for example, among patients with the same severity of dementia, tests that evaluate individual cognitive areas revealed differences depending on the presence or absence of periventricular MRI-LA.42 44 Among nondemented subjects, MRI-LA influences mental tasks involving speed of mental processing and attention.28 75 90 95 107 Because not all of these differences are obvious, their clinical significance should be reexamined. Two studies report that subjective memory impairment is more frequently noted by subjects with MRI-LA than by those without LA.28 77
In evaluating the effect of neuroimaging abnormalities on cognitive prowess, atrophy of corpus callosum and enlarged caliber of the lateral ventricles should be weighed; both of these could be equally as important93 109 112 as or more important113 than LA in determining cognitive deterioration. The marked atrophy of the cerebral white matter in advanced stages of leukoencephalopathy may lead to ex vacuo enlargement of the lateral ventricles; at least one study has shown a positive correlation between the severity of MRI-LA and ventricular enlargement.93
Other Clinical Findings
In addition to cognitive impairment, gait
disturbances,31 49 65 68 97 tendency to
fall,111 extensor plantar reflex,48 65 97 and
primitive reflexes65 90 97 are the most common
neurological abnormalities associated with LA, and their existence is
thought to be related to injury to the subcortical brain regions. An
increased prevalence of MRI-LA has been recently described in a variety
of psychiatric disorders.80 114 115 116 117 118 119 120 121 122 123 124 125 However, some of these
studies are noncontrolled, are based on small numbers of patients, and
do not take into account associated risk factors; therefore, many of
these observations await corroboration.
Prognostic Significance
The presence of LA in patients with history of
cerebrovascular accidents101 126 or probable
AD55 suggests an increased incidence of subsequent stroke.
However, LA may be only one of the poor prognosis indicators; the true
determinants are aging, arterial hypertension, presence of lacunes on
CT, and electrocardiographic abnormalities.127 LA does not
seem to influence the progression of global cognitive impairment in AD
patients,86 108 128 and in normal subjects LA is
associated only with a more rapid decline in visuospatial, associative,
and psychomotor functions.92 A clinicopathologic study
showed early death occurrence and faster progression of mental
impairment among AD patients who had pathological evidence of more
severe decrease in the number of myelinated fibers,
suggesting that the severity of LA, rather than its presence, is a
reliable prognostic factor.62
CADASIL
Recently a condition first described in 1977129 and
characterized by multiple subcortical infarcts, leukoencephalopathy,
and an autosomal dominant pattern of inheritance (CADASIL [cerebral
autosomal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy]) has received new attention after the genetic
defect was mapped to chromosome 19q12.130 CADASIL is
clinically characterized by recurrent strokes and a terminal picture of
dementia; pathologically, small deep infarcts and leukoencephalopathy
are associated with a concentric thickening of the wall of the small
vessels secondary to granular eosinophilic deposits in the tunica
media.131 132 At present, CADASIL accounts for only a
very small number of cases with LA,133 but close study of
this condition could shed light on the pathogenesis of white matter
abnormalities related to small-vessel disease.
Pathological Correlates
Understanding the pathological correlates of LA might help
to elucidate the pathogenesis of these lesions. The correlation between
LA and postmortem findings has been evaluated in cases in which CT or
MRI showed LA at a time closely related to autopsy or in cases in which
postmortem MRI examination of the brain was completed. Although fewer
white matter abnormalities are noted postmortem compared with in vivo
MRI,134 the postmortem observations are considered
valuable.135 136
Periventricular LA correlates with decreased myelin content,137 138 139 140 141 142 143 144 loss of ependymal cell layer and reactive gliosis (also called granular ependymitis) at the tip of the frontal horns,137 138 139 140 141 143 145 increased periependymal extracellular fluid content, and smaller and fewer axons.138 Some authors have also found enlarged perivascular spaces at this periventricular location.141 Small periventricular lesions exist in all age groups (including newborns)138 144 ; therefore, such findings probably do not constitute a true abnormality.
The histological correlates of deep subcortical MRI-LA are even less consistent than those noted for periventricular LA. Punctate abnormalities correspond to enlarged perivascular spaces,137 143 small cavitary infarcts (or lacunes),146 147 148 demyelinating plaques, brain cysts, and congenital diverticula of the lateral ventricles.147 MRI methods seem adequate to distinguish between enlarged Virchow-Robin spaces and lacunar infarcts,145 149 but in some cases the corresponding pathological abnormality of punctate lesions was undetectable.134 142 147 148 The more diffuse lesions in the centrum semiovale have been related to myelin rarefaction that spares the U fibers,135 137 sometimes accompanied by astrogliosis,139 and to diffuse vacuolization of the white matter.148 The myelin rarefaction does not correspond to true demyelination since the process also involves destruction of the axons.62 135 150 151 Thickening of the wall of the small vessels is also found in these areas.135 139 140 142 146 151 For these diffuse subcortical lesions the radiological-pathological correlation is not very tight: myelin loss is sometimes present in areas without LA151 or is more extensive than shown by MRI.151
|
Conclusions |
|---|
|
TopAbstractIntroductionHistorical OverviewLeukoaraiosisConclusionsReferences |
|---|
Nomenclature
According to some authors Binswanger's disease has well-defined neuropathological features,152 153 154 while others suggest validation of clinical criteria155 based on pathological characteristics attributed to Olszewski.6 However, the pathological criteria remain vaguely outlined, and Binswanger's original description is clearly insufficient to define a new nosological entity. Many cases described under the eponym Binswanger's disease share some pathological findings,7 16 156 157 but the same type of histological abnormalities can also be seen in a wide variety of unrelated conditions.63 158 159 We believe that the term Binswanger's disease should be avoided. Instead, the more descriptive terms of LA and subcortical leukoencephalopathy can be reserved for the radiological and pathological communications.
Clinical Significance of LA
The clinical significance of LA remains incompletely defined.
However, some conclusions seem warranted at this time. (1) LA is part
of the aging process; the addition of cerebrovascular risk factors
aggravates LA. (2) In subjects who have no or only moderate cognitive
impairment, LA, especially of the most severe degrees, influences
specific cognitive functions, such as those involving speed of mental
processes. LA may also contribute to the cognitive decline in patients
with AD and VaD, but to demonstrate a correlation once the dementia is
fully developed is extremely arduous. (3) Persons with LA have an
increased risk of cerebrovascular events. It remains to be shown
whether this conclusion can be applied only to specific categories of
patients, eg, those with previous cerebrovascular accidents.
Possible Causes of Inconsistency in Past Studies
Uncertainties regarding the significance of LA stem from our poor
understanding of its pathogenesis160 161 and the
incomplete definition of its pathological features. Factors that may
account for the discrepancy in results obtained in large numbers of
epidemiological studies include (1) small numbers and
heterogeneous cohorts of patients, (2) application of
different classifications of LA, and (3) use of disparate
neuropsychological tests. An added source of possible variability
includes poor interobserver agreement on the radiological assessment of
LA; among CT-based studies this agreement was substantial in
three96 102 162 and almost perfect in two
studies.99 163 The interobserver agreement in the
evaluation of MRI-LA was moderate in one,96 substantial in
three,56 87 164 and almost perfect in another
study.76
Future Approaches
Three future endeavors are recommended: (1) to define the
responses of white matter to various types of ischemic injury
in suitable experimental models, (2) to explore the potential vascular
pathogenesis of specific types of leukoencephalopathy associated with a
genetic pattern of inheritance, and (3) to investigate the clinical and
pathological correlates of distinct degrees of severity of LA
(especially MRI-LA) in well-defined populations and at specific brain
locations. In this context the adoption of a uniform neuroimaging
nomenclature and the application of uniform and specific
neuropsychological tests will be invaluable. A multicenter study could
provide the large number of observations necessary to conduct the
required statistical analyses.
|
Acknowledgments |
|---|
We thank Drs S.R. Levine (Detroit, Mich), G.G. Brown (Detroit, Mich), and G. Molinari (Easton, Md) for their valuable contributions during the embryonic stages of manuscript preparation and Paula McGee, Lisa Pietrantoni, and Kathy Zajas for their secretarial assistance.
Received February 28, 1995; revision received April 12, 1995; accepted April 12, 1995.
|
References |
|---|
|
TopAbstractIntroductionHistorical OverviewLeukoaraiosisConclusionsReferences |
|---|
1. Binswanger O. Die Abgrenzung der allgemeinen progressiven Paralyse. Berl Klin Wochenschr. 1894;31:1102-1105,1137-1139,1180-1186.
2.
Blass JP, Hoyer S, Nitsch R. A translation of
Otto Binswanger article, `The delineation of the generalized
progressive paralyses.' Arch Neurol. 1991;48:961-972.
3. Schneider R, Wieczorek V. Otto Binswanger (1852-1929). J Neurol Sci. 1991;103:61-64.[Medline] [Order article via Infotrieve]
4. Alzheimer A. Die Seelenstörungen auf arteriosklerotischer Grundlage. Allg Z Psychiat. 1902;59:695-701.
5.
Schorer CE. Alzheimer and Kraeplin describe
Binswanger's disease. J Neuropsychiatry Clin
Neurosci. 1992;4:55-58.
6. Olszewski J. Subcortical arteriosclerotic encephalopathy. World Neurol. 1962;3:359-375.
7.
Babikian V, Ropper AH. Binswanger's disease:
a review. Stroke. 1987;18:2-12.
8.
Rosenberg GA, Kornfeld M, Stovring J, Bicknell JM.
Subcortical arteriosclerotic encephalopathy (Binswanger):
computerized tomography. Neurology. 1979;29:1102-1106.
9. Young IR, Randell CP, Kaplan PW, James A, Bydder GM, Steiner RE. Nuclear magnetic resonance (NMR) imaging in white matter disease of the brain using spin-echo sequences. J Comput Assist Tomogr. 1983;7:290-294. [Medline] [Order article via Infotrieve]
10.
Loizou LA, Kendall BE, Marshall J. Subcortical
arteriosclerotic encephalopathy: a clinical and radiological
investigation. J Neurol Neurosurg
Psychiatry. 1981;44:294-304.
11. Tomonaga M, Yamanouchi H, Tohgi H, Kameyama M. Clinicopathologic study of progressive subcortical vascular encephalopathy (Binswanger type) in the elderly. J Am Geriatr Soc. 1982;30:524-529. [Medline] [Order article via Infotrieve]
12.
Kinkel WR, Jacobs L, Polachini I, Bates V, Heffner
RR. Subcortical arteriosclerotic encephalopathy (Binswanger's
disease): computed tomographic, nuclear magnetic resonance, and
clinical correlations. Arch Neurol. 1985;42:951-959.
13.
Kinkel WR, Jacobs L, Polachini I, Bates V,
Heffner RR. Binswanger's disease. Arch
Neurol. 1986;43:641-642.
14. Bradley WG Jr, Waluch V, Brandt-Zawadzki M, Yadley RA, Wycoff RR. Patchy, periventricular white matter lesions in the elderly: a common observation during NMR imaging. Noninv Med Imag. 1984;1:35-41.
15.
Gerard G, Weisberg LA. MRI periventricular
lesions in adults. Neurology. 1986;36:998-1001.
16.
Román GC. Senile dementia of the
Binswanger type: a vascular form of dementia in the elderly.
JAMA. 1987;258:1782-1788.
17.
Román GC. Why not Binswanger's
disease? Arch Neurol. 1988;45:141-142.
18. Hachinski VC, Potter P, Merskey H. Leuko-araiosis: an ancient term for a new problem. Can J Neurol Sci. 1986;13:533-534. [Medline] [Order article via Infotrieve]
19.
Hachinski VC, Potter P, Merskey H.
Leuko-araiosis. Arch Neurol. 1987;44:21-23.
20.
Erkinjuntti T, Ketonen L, Sulkava R, Sipponen J,
Vuorialho M, Iivanainen M. Do white matter changes on MRI and CT
differentiate vascular dementia from Alzheimer's
disease? J Neurol Neurosurg Psychiatry. 1987;50:37-42.
21.
Johnson KA, Davis KR, Buonanno FS, Brady TJ, Rosen J,
Growdon JH. Comparison of magnetic resonance and roentgen ray
computed tomography in dementia. Arch Neurol. 1987;44:1075-1080.
22. George AE, de Leon MJ, Kalnin A, Rosner L, Goodgold A, Chase N. Leukoencephalopathy in normal and pathologic aging, II: MRI of brain lucencies. AJNR Am J Neuroradiol. 1986;7:567-570. [Abstract]
23.
Bradley WG Jr, Waluch V, Yadley RA, Wycoff RR.
Comparison of CT and MR in 400 patients with suspected disease
of the brain and cervical spinal cord. Radiology. 1984;152:695-702.
24.
Brant-Zawadzki M, David PL, Crooks LE, Mills
CM, Norman D, Newton TH, Sheldon P, Kaufman L. NMR demonstration
of cerebral abnormalities: comparison with CT. AJR Am J
Roentgenol. 1983;140:847-854.
25. Zimmerman RD, Fleming CA, Lee BCP, Saint-Louis LA, Deck MDF. Periventricular hyperintensity as seen by magnetic resonance: prevalence and significance. AJNR Am J Neuroradiol. 1986;7:13-20.
26. Salgado ED, Weistein M, Furlan AJ, Modic MT, Beck GJ, Estes M, Awad I, Little JR. Proton magnetic imaging in ischemic cerebrovascular disease. Ann Neurol. 1986;20:502-507. [Medline] [Order article via Infotrieve]
27.
Lechner H, Schmidt R, Bertha G, Justich E,
Offenbacher H, Schneider G. Nuclear magnetic resonance image
white matter lesions and risk factors for stroke in normal
individuals. Stroke. 1988;19:263-265.
28.
Gupta SR, Naheedy MH, Young JC, Ghobrial M, Rubino
FA, Hindo W. Periventricular white matter changes and dementia:
clinical, neuropsychological, radiological, and pathological
correlation. Arch Neurol. 1988;45:637-641.
29. Inzitari D, Mascalchi M. Leuko-araiosis: a reappraisal, I: CT studies. Ital J Neurol Sci. 1990;11:241-248. [Medline] [Order article via Infotrieve]
30. Kobari M, Meyer JS, Ichijo M, Oravez WT. Leukoaraiosis: correlation of MR and CT findings with blood flow, atrophy, and cognition. AJNR Am J Neuroradiol. 1990;11:273-281. [Abstract]
31. London E, de Leon MJ, George AE, Englund E, Ferris S, Gentes C, Reisberg B. Periventricular lucencies in the CT scans of aged and demented patients. Biol Psychiatry. 1986;21:960-962. [Medline] [Order article via Infotrieve]
32.
Inzitari D, Diaz F, Fox A, Hachinski VC, Steingart A,
Lau C, Donald A, Wade J, Mulic H, Merskey H. Vascular risk
factors and leuko-araiosis. Arch Neurol. 1987;44:42-47.
33. Erkinjuntti T, Ketonen L, Sulkava R, Vuorialho M, Palo J. CT in the differential diagnosis between Alzheimer's disease and vascular dementia. Acta Neurol Scand. 1987;75:262-270. [Medline] [Order article via Infotrieve]
34.
Aharon-Peretz J, Cummings JL, Hill MA.
Vascular dementia and dementia of the Alzheimer type: cognition,
ventricular size, and leuko-araiosis. Arch Neurol. 1988;45:719-721.
35. Wallin A, Blennow K, Uhlemann C, Langstrom G, Gottfries CG. White matter low attenuation on computed tomography in Alzheimer's disease and vascular dementia: diagnostic and pathogenetic aspects. Acta Neurol Scand. 1989;80:518-523. [Medline] [Order article via Infotrieve]
36. Jayakumar PN, Taly AB, Shanmugam V, Nagaraja D, Arya BYT. Multi-infarct dementia: a computed tomographic study. Acta Neurol Scand. 1989;73:292-295.
37. Parnetti L, Mecocci P, Santucci C, Gaiti A, Petrini A, Longo A, Cadini D, Caputo N, Signorini E, Senin U. Is multi-infarct dementia representative of vascular dementia? A retrospective study. Acta Neurol Scand. 1990;81:484-487. [Medline] [Order article via Infotrieve]
38.
Kobari M, Meyer JS, Ichijo M. Leuko-araiosis,
cerebral atrophy, and cerebral perfusion in normal aging.
Arch Neurol. 1990;47:161-165.
39. Räihä I, Tarvonen S, Kurki T, Rajala T, Sourander L. Relationship between vascular factors and white matter low attenuation of the brain. Acta Neurol Scand. 1993;87:286-289. [Medline] [Order article via Infotrieve]
40. Fazekas F, Chawluk JB, Alavi A, Hurtig H, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJNR Am J Neuroradiol. 1987;8:421-426.
41.
Hershey LA, Modic MT, Greenough PG, Jaffe DF.
Magnetic resonance imaging in vascular dementia.
Neurology. 1987;37:29-36.
42.
Kertesz A, Polk M, Carr T. Cognition and white
matter changes on magnetic resonance imaging in dementia.
Arch Neurol. 1990;47:387-391.
43.
Mirsen TR, Lee DH, Wong CJ, Diaz JF, Fox AJ,
Hachinski VC, Merskey H. Clinical correlates of white-matter
changes on magnetic resonance imaging scans of the brain.
Arch Neurol. 1991;48:1015-1021.
44.
Almkvist O, Wahlund L-O, Andersson-Lundman G, Basun
H, Bäckman L. White-matter hyperintensity and
neuropsychological functions in dementia and healthy aging.
Arch Neurol. 1992;49:626-632.
45. Schmidt R. Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging. Eur Neurol. 1992;32:164-169. [Medline] [Order article via Infotrieve]
46.
Liu CK, Miller BL, Cummings JL, Mehringer CM,
Goldberg MA, Howng SL, Benson DF. A quantitative MRI study of
vascular dementia. Neurology. 1992;42:138-143.
47. Wahlund L-O, Basun H, Almkvist O, Andersson-Lundman G, Julin P, Sääf J. White matter hyperintensities in dementia: does it matter? Magn Reson Imaging. 1994;12:387-394. [Medline] [Order article via Infotrieve]
48.
Steingart A, Hachinski VC, Lau C, Fox AJ, Fox H, Lee
D, Inzitari D, Merskey H. Cognitive and neurologic findings in
demented patients with diffuse white matter lucencies on computed
tomographic scan (leuko-araiosis). Arch Neurol. 1987;44:36-39.
49. George AE, de Leon MJ, Gentes CI, Miller J, London E, Budzilovich GN, Ferris S, Chase N. Leukoencephalopathy in normal and pathologic aging, I: CT of brain lucencies. AJNR Am J Neuroradiol. 1986;7:561-566. [Abstract]
50.
Rezek DL, Morris JC, Fulling KH, Gado MH.
Periventricular white matter lucencies in senile dementia of the
Alzheimer type and in normal aging. Neurology. 1987;37:1365-1368.
51. Erkinjuntti T, Sulkava R, Palo J, Ketonen L. White matter low attenuation on CT in Alzheimer's disease. Arch Gerontol Geriatr. 1989;8:95-104. [Medline] [Order article via Infotrieve]
52.
Fazekas F, Alavi A, Chawluk JB, Zimmerman RA, Hackney
D, Bilaniuk L, Rosen M, Alves WM, Hurtig HI, Jamieson DG, Kushner MJ,
Reivich M. Comparison of CT, MR, and PET in Alzheimer's
dementia and normal aging. J Nucl Med. 1989;30:1607-1615.
53.
Diaz JF, Merskey H, Hachinski VC, Lee DH, Boniferro
M, Wong CJ, Mirsen TR, Fox H. Improved recognition of
leukoaraiosis and cognitive impairment in Alzheimer's
disease. Arch Neurol. 1991;48:1022-1025.
54. Blennow K, Wallin A, Uhlemann C, Gottfries CG. White-matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors. Acta Neurol Scand. 1991;83:187-193. [Medline] [Order article via Infotrieve]
55.
Lopez OL, Becker JT, Rezek D, Wess J, Boller F,
Reynolds CF III, Panisset M. Neuropsychiatric correlates of
cerebral white-matter radiolucencies in probable Alzheimer's
disease. Arch Neurol. 1992;49:828-834.
56.
Kozachuk WE, DeCarli C, Schapiro MB, Wagner EE,
Rapoport SI, Horwitz B. White matter hyperintensities in
dementia of Alzheimer's type and in healthy subjects without
cerebrovascular risk factors: a magnetic resonance imaging
study. Arch Neurol. 1990;47:1306-1310.
57.
Waldemar G, Christiansen P, Larsson HBW, Høgh P,
Laursen H, Lassen NA, Paulson OB. White matter magnetic
resonance hyperintensities in dementia of the Alzheimer type:
morphological and regional cerebral blood flow correlates.
J Neurol Neurosurg Psychiatry. 1994;57:1458-1465.
58. Wilson RS, Bennett D, Fox JH, Gilley DW, Huckman MS, Crame ACO, McCluney K, Geremia GK. Alzheimer's disease: prevalence and clinical significance of white-matter lesions on magnetic resonance imaging. Ann Neurol. 1988;24:160-161.
59.
Bondareff W, Raval J, Colletti PM, Hauser DL.
Quantitative magnetic resonance imaging and the severity of
dementia in Alzheimer's disease. Am J
Psychiatry. 1988;145:853-856.
60. McDonald WM, Krishnan KRR, Doraiswamy PM, Figiel GS, Husain MM, Boyko OB, Heyman A. Magnetic resonance findings in patients with early-onset Alzheimer's disease. Biol Psychiatry. 1991;29:799-810. [Medline] [Order article via Infotrieve]
61. Bowen BC, Barker WW, Loewenstein DA, Sheldon J, Duara R. MR signal abnormalities in memory disorders and dementia. AJNR Am J Neuroradiol. 1990;11:283-290. [Abstract]
62.
Janota I, Mirsen TR, Hachinski VC, Lee DH, Merskey H.
Neuropathological correlates of leuko-araiosis.
Arch Neurol. 1989;46:1124-1128.
63. Gray F, Dubas F, Rouller E, Escourolle R. Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol. 1985;18:54-59. [Medline] [Order article via Infotrieve]
64.
Harrell LE, Duvall E, Folks DG, Duke L, Bartolucci A,
Conboy T, Callaway R, Kerns D. The relationship of
high-intensity signals on magnetic resonance images to cognitive and
psychiatric state in Alzheimer's disease. Arch
Neurol. 1991;48:1136-1140.
65.
Steingart A, Hachinski VC, Lau C, Fox AJ, Diaz F,
Cape R, Lee D, Inzitari D, Merskey H. Cognitive and neurologic
findings in subjects with diffuse white matter lucencies on computed
tomographic scan (leuko-araiosis). Arch Neurol. 1987;44:32-35.
66.
Fazekas F, Niederkorn K, Schmidt R, Offenbacher H,
Horner S, Bertha G, Lechner H. White matter signal abnormalities
in normal individuals: correlation with carotid ultrasonography,
cerebral blood flow measurements, and cerebrovascular risk
factors. Stroke. 1988;19:1285-1288.
67.
Rao SM, Mittenberg W, Bernardin L, Haughton V, Leo
GJ. Neuropsychological test findings in subjects with
leucoaraiosis. Arch Neurol. 1989;46:40-44.
68. Hendrie HC, Farlow MR, Austrom Guerriero M, Edwards MK, Williams MA. Foci of increased T2 signal intensity on brain MR scans of healthy elderly subjects. AJNR Am J Neuroradiol. 1989;10:703-707. [Abstract]
69.
Hunt AL, Orrison WW, Yeo RA, Haaland KY, Rhyne RL,
Garry PJ, Rosenberg GA. Clinical significance of MRI white
matter lesions in the elderly. Neurology. 1989;39:1470-1474.
70. Fazekas F. Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur Neurol. 1989;29:164-168. [Medline] [Order article via Infotrieve]
71.
Zubenko GS, Sullivan P, Nelson JP, Belle SH, Huff J,
Wolf GL. Brain imaging abnormalities in mental disorders of late
life. Arch Neurol. 1990;47:1107-1111.
72.
Schmidt R, Fazekas F, Offenbacher H, Lytwyn H,
Blematl B, Niederkorn K, Horner S, Payer F, Freidl W. Magnetic
resonance imaging white matter lesions and cognitive impairment in
hypertensive individuals. Arch Neurol. 1991;48:417-420.
73.
Boone KB, Miller BL, Lesser IM, Mehringer CM,
Hill-Gutierrez E, Goldberg MA, Berman NG. Neuropsychological
correlates of white-matter lesions in healthy elderly subjects: a
threshold effect. Arch Neurol. 1992;49:549-554.
74.
Tupler LA, Coffey CE, Logue PE, Djang WT, Fagan SM.
Neuropsychological importance of subcortical white matter
hyperintensity. Arch Neurol. 1992;49:1248-1252.
75.
Schmidt R, Fazekas F, Offenbacher H, Dusek T, Zach E,
Reinhart B, Grieshofer P, Freidl W, Eber B, Schumacher M, Koch M,
Lechner H. Neuropsychological correlates of MRI white matter
hyperintensities: a study of 150 normal volunteers.
Neurology. 1993;43:2490-2494.
76. Lindgren A, Roijer A, Rudling O, Norrving B, Larsson E-M, Eskilsson J, Wallin L, Olsson B, Johansson BB. Cerebral lesions on magnetic resonance imaging, heart disease, and vascular risk factors in subjects without stroke. Stroke. 1994;25:929-934. [Abstract]
77.
Breteler MMB, van Swieten JC, Bots ML, Grobbee DE,
Claus JJ, van den Hout, van Harskamp F, Tanghe HLJ, de Jong PTVM, van
Gijn J, Hofman A. Cerebral white matter lesions, vascular risk
factors, and cognitive function in a population-based study: the
Rotterdam Study. Neurology. 1994;44:1246-1252.
78.
Kertesz A, Black SE, Tokar G, Benke T, Carr T,
Nicholson L. Periventricular and subcortical hyperintensities on
magnetic resonance imaging: `rims, caps, and unidentified bright
objects.' Arch Neurol. 1988;45:404-408.
79.
Sarpel G, Chaundry F, Hindo W. Magnetic
resonance imaging of periventricular hyperintensity in a Veterans
Administration hospital population. Arch Neurol. 1987;44:725-728.
80.
Coffey CE, Figiel GS, Djang WT, Saunders WB, Weiner
RD. White matter hyperintensity on magnetic resonance imaging:
clinical and neuroanatomic correlates in the depressed elderly.
J Neuropsychiatry Clin Neurosci. 1989;1:135-144.
81.
Hijdra A, Verbeeten B Jr, Verhulst JAPM.
Relation of leukoaraiosis to lesion type in stroke
patients. Stroke. 1990;21:890-894.
82.
Schmidt R, Fazekas F, Kleinert G, Offenbacher H,
Gindl K, Payer F, Freidl W, Niederkorn K, Lechner H. Magnetic
resonance imaging signal hyperintensities in the deep and subcortical
white matter: a comparative study between stroke patients and normal
volunteers. Arch Neurol. 1992;49:825-827.
83.
Erkinjuntti T, Gao F, Lee DH, Eliasziw M, Merskey H,
Hachinski VC. Lack of difference in brain hyperintensities
between patients with early Alzheimer's disease and control
subjects. Arch Neurol. 1994;51:260-268.
84.
Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R.
Incidental subcortical lesions identified on magnetic resonance
imaging in the elderly, I: correlation with age and cerebrovascular
risk factors. Stroke. 1986;17:1084-1089.
85. van Swieten JC, Geyskes GG, Derix MMA, Peeck BM, Ramos LMP, van Latum JC, van Gijn J. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol. 1991;30:825-830. [Medline] [Order article via Infotrieve]
86. Morris JC, Gado MH, Grant EA, Rezek DL. Periventricular white matter lucencies: no effect on the natural history of senile dementia of the Alzheimer type. Ann Neurol. 1988;24:159-160.
87.
Sullivan P, Pary R, Telang F, Rifai AH, Zubenko GS.
Risk factors for white matter changes detected by magnetic
resonance imaging in the elderly. Stroke. 1990;21:1424-1428.
88.
Bondareff W, Raval J, Woo B, Hauser DL, Colletti PM.
Magnetic resonance imaging and the severity of dementia in older
adults. Arch Gen Psychiatry. 1990;47:47-51.
89.
Scheltens PH, Barkhof F, Valk J, Algra PR, Gerritsen
van der Hoop R, Nauta J, Wolters ECH. White matter lesions on
magnetic resonance imaging in clinically diagnosed Alzheimer's
disease. Brain. 1992;115:735-748.
90.
Junqué C, Pujol J, Vendrell P, Bruna O, Jodar
M, Ribas JC, Vinas J, Capdevila A, Marti-Vilalta JL.
Leuko-araiosis on magnetic resonance imaging and speed of mental
processing. Arch Neurol. 1990;47:151-156.
91. Duara R, Barker W, Loewenstein D, Pascal S, Bowen B. Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer's disease and multi-infarct dementia. Eur Neurol. 1989;29:9-15.
92. Austrom Guerriero M, Thompson RF Jr, Hendrie HC, Norton J, Farlow MR, Edwards MK, Dean R. Foci of increased T2 signal intensity in MR images of healthy elderly subjects: a follow-up study. J Am Geriatr Soc. 1990;38:1133-1138. [Medline] [Order article via Infotrieve]
93. Breteler MMB, van Amerongen NM, van Swieten JC, Claus JJ, Grobbee DE, van Gijn J, Hofman A, van Harskamp F. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging: the Rotterdam Study. Stroke. 1994;25:1109-1115. [Abstract]
94.
Matsubayashi K, Shimada K, Kawamoto A, Ozaka T.
Incidental brain lesions on magnetic resonance imaging and
neurobehavioral functions in the apparently healthy elderly.
Stroke. 1992;23:175-180.
95.
Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R,
Raininko R, Tilvis R. White matter changes in healthy elderly
persons correlate with attention and speed of mental
processing. Arch Neurol. 1993;50:818-824.
96.
Leys D, Soetaert G, Petit H, Fauquette A, Pruvo J-P,
Steinling M. Periventricular and white matter magnetic resonance
imaging hyperintensities do not differ between Alzheimer's
disease and normal aging. Arch Neurol. 1990;47:524-527.
97. Cadelo M, Inzitari D, Pracucci G, Mascalchi M. Predictors of leukoaraiosis in elderly neurological patients. Cerebrovasc Dis. 1991;1:345-351.
98. Meyer JS, Takashima S, Terayama Y, Obara K, Muramatsu K, Weathers S. CT changes associated with normal aging of the human brain. J Neurol Sci. 1994;123:200-208. [Medline] [Order article via Infotrieve]
99.
Streifler JY, Eliasziw M, Benavente OR, Hachinski VC,
Fox AJ, Barnett HJM, for the North American Symptomatic Carotid
Endarterectomy Trial. Lack of relationship between leukoaraiosis
and carotid artery disease. Arch Neurol. 1995;52:21-24.
100.
Bogousslavsky J, Regli F, Uske A.
Leukoencephalopathy in patients with ischemic
stroke. Stroke. 1987;18:896-899.
101. van Swieten JC, Kappelle LJ, Algra A, van Latum JC, Koudstaal PJ, van Gijn J, for the Dutch TIA Trial Study Group. Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Ann Neurol. 1992;32:177-183. [Medline] [Order article via Infotrieve]
102.
Inzitari D, Giordano GP, Ancona AL, Pracucci G,
Mascalchi M, Amaducci L. Leukoaraiosis,
intracerebral hemorrhage, and arterial
hypertension. Stroke. 1990;21:1419-1423.
103. Ostrow PT, Miller LL. Pathology of small artery disease. Adv Neurol. 1993;62:93-123. [Medline] [Order article via Infotrieve]
104.
Matsushita K, Kuriyama Y, Nagatsuka K, Nakamura M,
Sawada T, Omae T. Periventricular white matter lucency and
cerebral blood flow autoregulation in hypertensive patients.
Hypertension. 1994;23:565-568.
105. De Reuck J. The human periventricular arterial blood supply and the anatomy of cerebral infarctions. Eur Neurol. 1971;5:321-334. [Medline] [Order article via Infotrieve]
106.
Fukuda H, Kobayashi S, Okada K, Tsunematsu T.
Frontal white matter lesions and dementia in lacunar
infarction. Stroke. 1990;21:1143-1149.
107. Fukui T, Sugita K, Sato Y, Takeuchi T, Tsukagoshi H. Cognitive functions in subjects with incidental cerebral hyperintensities. Eur Neurol. 1994;34:272-276. [Medline] [Order article via Infotrieve]
108.
Harrell LE, Duvall E, Folks D, Kinney C, Duke L,
Marson D, Bartolucci A, Callaway R, Forsyth P. Do white matter
changes predict progression in Alzheimer's disease?
Neurology. 1992;42:276.
109.
Tanaka Y, Tanaka O, Mizuno Y, Yoshida M. A
radiologic study of dynamic processes in lacunar dementia.
Stroke. 1989;20:1488-1493.
110.
Loeb C, Gandolfo C, Croce R, Conti M. Dementia
associated with lacunar infarction. Stroke. 1992;23:1225-1229.
111.
Masdeu JC, Wolfson L, Lantos G, Tobin JN, Grober E,
Whipple R, Amerman P. Brain white-matter changes in the elderly
prone to falling. Arch Neurol. 1989;46:1292-1296.
112. Pujol J, Junqué C, Vendrell P, Capdevila A, Martí-Vilalta JL. Cognitive correlates of ventricular enlargement in vascular patients with leuko-araiosis. Acta Neurol Scand. 1991;84:237-242. [Medline] [Order article via Infotrieve]
113. Bracco L, Campani D, Baratti E, Lippi A, Inzitari D, Pracucci G, Amaducci L. Relation between MRI features and dementia in cerebrovascular disease patients with leucoaraiosis: a longitudinal study. J Neurol Sci. 1993;120:131-136. [Medline] [Order article via Infotrieve]
114. Krishnan KRR, Goli V, Ellinwood EH, France RD, Blazer DG, Nemeroff CB. Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry. 1988;23:519-522. [Medline] [Order article via Infotrieve]
115. Coffey CE, Figiel GS, Djang WT, Cress M, Saunders WB, Weiner RD. Leukoencephalopathy in elderly depressed patients referred for ECT. Biol Psychiatry. 1988;24:143-161. [Medline] [Order article via Infotrieve]
116.
Coffey CE, Figiel GS, Djang WT, Weiner RD.
Subcortical hyperintensity on magnetic resonance imaging: a
comparison of normal and depressed elderly subjects. Am J
Psychiatry. 1990;147:187-189.
117. Breitner JCS, Husain MM, Figiel GS, Krishnan KRR, Boyko OB. Cerebral white matter disease in late-onset paranoid psychosis. Biol Psychiatry. 1990;28:266-274. [Medline] [Order article via Infotrieve]
118.
Dupont RM, Jernigan TL, Butters N, Delis D, Hesseling
JR, Heindel W, Gillin C. Subcortical abnormalities detected in
bipolar affective disorder using magnetic resonance imaging.
Arch Gen Psychiatry. 1990;47:55-59.
119.
Swayze VW II, Andreasen NC, Alliger RJ, Ehrhardt JC,
Yuh WTC. Structural brain abnormalities in bipolar affective
disorder. Arch Gen Psychiatry. 1990;47:1054-1059.
120.
Fiegel GS, Krishnan KRR, Rao VP, Doraiswamy M,
Ellinwood EH Jr, Nemeroff CB, Evans D, Boyko O. Subcortical
hyperintensities on brain magnetic resonance imaging: a comparison of
normal and bipolar subjects. J Neuropsychiatry
Clin Neurosci. 1991;3:18-22.
121. McDonald WM, Krishnan KRR, Doraiswamy PM, Blazer DG. Occurrence of subcortical hyperintensities in elderly subjects with mania. Psychiatry Res Neuroimaging. 1991;40:211-220.
122.
Aylward EH, Roberts-Twillie JV, Barta PE, Kumar AJ,
Harris GJ, Geer M, Peyser CE, Pearlson GD. Basal ganglia volumes
and white matter hyperintensities in patients with bipolar
disorder. Am J Psychiatry. 1994;151:687-693.
123. Hickie I, Scott E, Mitchell P, Wilhelm K, Austin M-P, Bennett B. Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry. 1995;37:151-160. [Medline] [Order article via Infotrieve]
124. Deicken RF, Reus VI, Manfredi L, Wolkowitz OM. MRI deep white matter hyperintensity in a psychiatric population. Biol Psychiatry. 1991;29:918-922. [Medline] [Order article via Infotrieve]
125.
Brown FW, Lewine RJ, Hudgins PA, Risch SC.
White matter hyperintensity signals in psychiatric and
nonpsychiatric subjects. Am J Psychiatry. 1992;149:620-625.
126.
Miyao S, Takano A, Teramoto J, Takahashi A.
Leukoaraiosis in relation to prognosis for patients with lacunar
infarction. Stroke. 1992;23:1434-1438.
127. Inzitari D, Di Carlo AS, Mascalchi M, Pracucci G, Amaducci L. The cardiovascular outcome of patient with motor impairment and extensive leuko-araiosis. Arch Neurol. In press.
128. Morris JC, Gado M, Torack RM, McKeel DW Jr. Binswanger's disease or artifact: a clinical, neuroimaging, and pathological study of periventricular white matter changes in Alzheimer's disease. Adv Neurol. 1990;51:47-52. [Medline] [Order article via Infotrieve]
129. Sourander P, Walinder J. Hereditary multi-infarct dementia. Acta Neuropathol. 1977;39:247-254. [Medline] [Order article via Infotrieve]
130. Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop GM, Chabriat H, Mas J-L, Cabanis E-A, Baudrimont M, Maciazek J, Bach M-A, Bousser M-G. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps on chromosome 19q12. Nat Genet. 1993;3:256-259. [Medline] [Order article via Infotrieve]
131.
Baudrimont M, Dubas F, Joutel A,
Tournier-Lasserve E, Bousser M-G. Autosomal dominant
leukoencephalopathy and subcortical ischemic stroke: a
clinicopathological study. Stroke. 1993;24:122-125.
132. Gray F, Robert F, Labrecque R, Chretien F, Baudrimont M, Fallet-Bianco C, Mikol J, Vinters HV. Autosomal dominant arteriopathic leuko-encephalopathy and Alzheimer's disease. Neuropathol Appl Neurobiol. 1994;20:22-30. [Medline] [Order article via Infotrieve]
133. Bowler JV, Hachinski V. Progress in the genetics of cerebrovascular disease: inherited subcortical arteriopathies. Stroke. 1994;25:1696-1698. [Medline] [Order article via Infotrieve]
134. Fazekas F, Kleinert R, Offenbacher H, Payer F, Schmidt R, Kleinert G, Radner H, Lechner H. The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR Am J Neuroradiol. 1991;12:915-921. [Abstract]
135.
Révész T, Hawkins CP, du Boulay
EPGH, Barnard RO, McDonald WI. Pathological findings
correlated with magnetic resonance imaging in subcortical
arteriosclerotic encephalopathy (Binswanger's disease).
J Neurol Neurosurg Psychiatry. 1989;52:1337-1344.
136. Boyko OB, Alston SR, Fuller GN, Hulette CM, Johnson GA, Burger PC. Utility of postmortem magnetic resonance imaging in clinical neuropathology. Arch Pathol Lab Med. 1994;118:219-225. [Medline] [Order article via Infotrieve]
137.
Chimowitz MI, Estes ML, Furlan AJ, Awad IA.
Further observations on the pathology of subcortical lesions
identified on magnetic resonance imaging. Arch
Neurol. 1992;49:747-752.
138. Sze G, De Armond SJ, Brant-Zawadzki M, Davis RL, Norman D, Newton TH. Foci of MRI signal (pseudolesions) anterior to the frontal horns: histologic correlations of a normal finding. AJNR Am J Neuroradiol. 1986;7:381-387.
139.
Fazekas F, Kleinert R, Offenbacher H, Schmidt R,
Kleinert G, Payer F, Radner H, Lechner H. Pathologic correlates
of incidental MRI white matter signal hyperintensities.
Neurology. 1993;43:1683-1689.
140.
Leifer D, Buonanno FS, Richardson EP Jr.
Clinicopathologic correlations of cranial magnetic resonance
imaging of periventricular white matter. Neurology. 1990;40:911-918.
141.
Grafton ST, Sumi SM, Stimac GK, Alvord EC Jr, Shaw
C-M, Nochlin D. Comparison of postmortem magnetic resonance
imaging and neuropathologic findings in the cerebral white
matter. Arch Neurol. 1991;48:293-298.
142.
van Swieten JC, van Den Hout JHW, van Ketel BA, Hijdra
A, Wokke JHJ, van Gijn J. Periventricular lesions in the white
matter on magnetic resonance imaging in the elderly: a morphometric
correlation with arteriolosclerosis and dilated perivascular
spaces. Brain. 1991;114:761-774.
143. Scarpelli M, Salvolini U, Diamanti L, Montironi R, Chiaromoni L, Maricotti M. MRI and pathological examination of post-mortem brains: the problem of white matter high signal areas. Neuroradiology. 1994;36:393-398. [Medline] [Order article via Infotrieve]
144.
Moody DM, Brown WR, Challa VR, Anderson RL.
Periventricular venous collagenosis: association with
leukoaraiosis. Radiology. 1995;194:469-476.
145.
Jungreis CA, Kanal E, Hirsch WL, Martinez AJ, Moossy
J. Normal perivascular spaces mimicking lacunar infarction: MR
imaging. Radiology. 1988;169:101-104.
146.
Marshall VG, Bradley WG Jr, Marshall CE, Bhoopat T,
Rhodes RH. Deep white matter infarction: correlation of MR
imaging and histopathologic findings. Radiology. 1988;167:517-522.
147. Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepfer WW. Brain MR: pathologic correlation with gross and histopathology, II: hyperintense white-matter foci in the elderly. AJNR Am J Neuroradiol. 1988;9:629-636.
148.
Muñoz DG, Hastak SM, Harper B, Lee D, Hachinski
VC. Pathologic correlates of increased signals of the centrum
ovale on magnetic resonance imaging. Arch Neurol. 1993;50:492-497.
149. Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepfer WW. Brain MR: pathologic correlation with gross and histopathology, I: lacunar infarction and Virchow-Robin spaces. AJNR Am J Neuroradiol. 1988;9:621-628.
150.
Awad IA, Johnson PC, Spetzler RF, Hodak JA.
Incidental subcortical lesions identified on magnetic resonance
imaging in the elderly, II: postmortem pathological
correlations. Stroke. 1986;17:1090-1097.
151. Lotz PR, Ballinger WE Jr, Quisling RG. Subcortical arteriosclerotic encephalopathy: CT spectrum and pathologic correlation. AJNR Am J Neuroradiol. 1986;7:817-822.
152.
Caplan LR, Schoene WC. Clinical features of
subcortical arteriosclerotic encephalopathy (Binswanger
disease). Neurology. 1978;28:1206-1215.
153.
De Reuck J, Crevits L, De Coster W, Sieben G, vander
Eecken H. Pathogenesis of Binswanger chronic progressive
subcortical encephalopathy. Neurology. 1980;30:920-928.
154. Bogucki A, Janczewska E, Koszewska I, Chmielowski M, Szymanska R. Evaluation of dementia in subcortical arteriosclerotic encephalopathy (Binswanger's disease). Eur Arch Psychiatry Clin Neurosci. 1991;241:91-97. [Medline] [Order article via Infotrieve]
155.
Bennett DA, Wilson RS, Gilley DW, Fox JH.
Clinical diagnosis of Binswanger's disease.
J Neurol Neurosurg Psychiatry. 1990;53:961-965.
156. Fisher CM. Binswanger's encephalopathy: a review. J Neurol. 1989;236:65-79. [Medline] [Order article via Infotrieve]
157. Pellissier J-F, Poncet M. Binswanger's encephalopathy. In: Toole JF, ed. Handbook of Clinical Neurology: Vascular Diseases, Part II. Amsterdam, Netherlands: Elsevier Science Publishers; 1989;10(54):221-233.
158. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol. 1986;19:253-262. [Medline] [Order article via Infotrieve]
159. Feigin I, Popoff N. Neuropathological changes late in cerebral edema: the relationship to trauma, hypertensive disease and Binswanger's encephalopathy. J Neuropathol Exp Neurol. 1963;32:500-511.
160.
Chimowitz MI, Awad IA, Furlan AJ.
Periventricular lesions on MRI: facts and theories.
Stroke. 1989;20:963-967.
161. Inzitari D, Marinoni M, Ginanneschi A, Mascalchi M, Pracucci G, Ancona AL, Piccininni MS, Di Carlo AS, Pantoni L. Pathophysiology of leucoaraiosis. In: Culebras A, Matías Guiu J, Román G, eds. New Concepts in Vascular Dementia. Barcelona, Spain: Prous Science; 1993:103-113.
162. Schneider R, Kluge R, Willmes K. Interrater agreement for CT scans of patients with lacunar infarcts and leuko-araiosis. Acta Neurol Scand. 1991;84:527-530. [Medline] [Order article via Infotrieve]
163.
Boiten J, Lodder J, Kessels F. Two clinical
distinct lacunar infarct entities? A hypothesis.
Stroke. 1993;24:652-656.
164.
van Swieten JC, Hijdra A, Koudstaal PJ, van Gijn J.
Grading white matter lesions on CT and MRI: a simple
scale. J Neurol Neurosurg Psychiatry. 1990;53:1080-1083.
This article has been cited by other articles:
 |
|
 |
|
  N K J Oksala, H Jokinen, S Melkas, A Oksala, T Pohjasvaara, M Hietanen, R Vataja, M Kaste, P J Karhunen, and T Erkinjuntti Cognitive impairment predicts poststroke death in long-term follow-up J. Neurol. Neurosurg. Psychiatry, November 1, 2009; 80(11): 1230 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kim, P Waters, A Vincent, S. Kim, H. Kim, Y. Hong, K. Park, J. Min, J. Sung, and K. Lee Sjogren's syndrome myelopathy: spinal cord involvement in Sjogren's syndrome might be a manifestation of neuromyelitis optica Multiple Sclerosis, September 1, 2009; 15(9): 1062 - 1068. [Abstract] [PDF]
|
|
|
|
 |
|
 T. D. Vannorsdall, S. R. Waldstein, M. Kraut, G. D. Pearlson, and D. J. Schretlen White Matter Abnormalities and Cognition in a Community Sample Arch Clin Neuropsychol, August 6, 2009; (2009) acp037v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Inzitari, G. Pracucci, A. Poggesi, G. Carlucci, F. Barkhof, H. Chabriat, T. Erkinjuntti, F. Fazekas, J. M Ferro, M. Hennerici, et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort BMJ, July 6, 2009; 339(jul06_1): b2477 - b2477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N K J Oksala, A Oksala, T Pohjasvaara, R Vataja, M Kaste, P J Karhunen, and T Erkinjuntti Age related white matter changes predict stroke death in long term follow-up J. Neurol. Neurosurg. Psychiatry, July 1, 2009; 80(7): 762 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Armario and A. de la Sierra Antihypertensive treatment and stroke prevention: are angiotensin receptor blockers superior to other antihypertensive agents? Therapeutic Advances in Cardiovascular Disease, June 1, 2009; 3(3): 197 - 204. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Saba, R. Sanfilippo, L. Pascalis, R. Montisci, and G. Mallarini Carotid Artery Abnormalities and Leukoaraiosis in Elderly Patients: Evaluation with MDCT Am. J. Roentgenol., February 1, 2009; 192(2): W63 - W70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M L Stromillo, M T Dotti, M Battaglini, M Mortilla, S Bianchi, K Plewnia, L Pantoni, D Inzitari, A Federico, and N De Stefano Structural and metabolic brain abnormalities in preclinical cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy J. Neurol. Neurosurg. Psychiatry, January 1, 2009; 80(1): 41 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.J. Huynh, B. Murphy, J.A. Pettersen, H. Tu, D.J. Sahlas, L. Zhang, S.P. Symons, S. Black, T.-Y. Lee, and R.I. Aviv CT Perfusion Quantification of Small-Vessel Ischemic Severity AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1831 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Miranda, S Madureira, A Verdelho, J Ferro, L Pantoni, E Salvadori, H Chabriat, T Erkinjuntti, F Fazekas, M Hennerici, et al. Self-perceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 869 - 873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Adami, G. Rossato, R. Cerini, V. N. Thijs, R. Pozzi-Mucelli, G. P. Anzola, M. D. Sette, C. Finocchi, G. Meneghetti, C. Zanferrari, et al. Right-to-left shunt does not increase white matter lesion load in migraine with aura patients Neurology, July 8, 2008; 71(2): 101 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Altaf, P. S. Morgan, A. Moody, S. T. MacSweeney, J. R. Gladman, and D. P. Auer Brain White Matter Hyperintensities Are Associated with Carotid Intraplaque Hemorrhage Radiology, July 1, 2008; 248(1): 202 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pantoni Leukoaraiosis: From an Ancient Term to an Actual Marker of Poor Prognosis Stroke, May 1, 2008; 39(5): 1401 - 1403. [Full Text] [PDF]
|
|
|
|
|
|
N. Levy-Cooperman, J. Ramirez, N. J. Lobaugh, and S. E. Black Misclassified Tissue Volumes in Alzheimer Disease Patients With White Matter Hyperintensities: Importance of Lesion Segmentation Procedures for Volumetric Analysis Stroke, April 1, 2008; 39(4): 1134 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Baezner, C. Blahak, A. Poggesi, L. Pantoni, D. Inzitari, H. Chabriat, T. Erkinjuntti, F. Fazekas, J. M. Ferro, P. Langhorne, et al. Association of gait and balance disorders with age-related white matter changes: The LADIS Study Neurology, March 18, 2008; 70(12): 935 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sachdev, W. Wen, X. Chen, and H. Brodaty Progression of white matter hyperintensities in elderly individuals over 3 years Neurology, January 16, 2007; 68(3): 214 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Inzitari, M. Simoni, G. Pracucci, A. Poggesi, A. M. Basile, H. Chabriat, T. Erkinjuntti, F. Fazekas, J. M. Ferro, M. Hennerici, et al. Risk of Rapid Global Functional Decline in Elderly Patients With Severe Cerebral Age-Related White Matter Changes: The LADIS Study Arch Intern Med, January 8, 2007; 167(1): 81 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Opherk, N. Peters, M. Holtmannspotter, A. Gschwendtner, B. Muller-Myhsok, and M. Dichgans Heritability of MRI Lesion Volume in CADASIL: Evidence for Genetic Modifiers Stroke, November 1, 2006; 37(11): 2684 - 2689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Munoz Leukoaraiosis and Ischemia: Beyond the Myth Stroke, June 1, 2006; 37(6): 1348 - 1349. [Full Text] [PDF]
|
|
|
|
|
|
M. S. Fernando, J. E. Simpson, F. Matthews, C. Brayne, C. E. Lewis, R. Barber, R. N. Kalaria, G. Forster, F. Esteves, S. B. Wharton, et al. White Matter Lesions in an Unselected Cohort of the Elderly: Molecular Pathology Suggests Origin From Chronic Hypoperfusion Injury * Annex - Supplemental Online-Only Content Stroke, June 1, 2006; 37(6): 1391 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Fazekas, S. Ropele, C. Enzinger, F. Gorani, A. Seewann, K. Petrovic, and R. Schmidt MTI of white matter hyperintensities Brain, December 1, 2005; 128(12): 2926 - 2932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Mosley Jr, D. S. Knopman, D. J. Catellier, N. Bryan, R. G. Hutchinson, C. A. Grothues, A. R. Folsom, L. S. Cooper, G. L. Burke, D. Liao, et al. Cerebral MRI findings and cognitive functioning: The Atherosclerosis Risk in Communities Study Neurology, June 28, 2005; 64(12): 2056 - 2062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Ferguson, A. Blane, J. Wardlaw, B. M. Frier, P. Perros, R. J. McCrimmon, and I. J. Deary Influence of an Early-Onset Age of Type 1 Diabetes on Cerebral Structure and Cognitive Function Diabetes Care, June 1, 2005; 28(6): 1431 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Moody, C. R. Thore, J. A. Anstrom, V. R. Challa, C. D. Langefeld, and W. R. Brown Quantification of Afferent Vessels Shows Reduced Brain Vascular Density in Subjects with Leukoaraiosis Radiology, December 1, 2004; 233(3): 883 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Wen and P. S. Sachdev Extent and Distribution of White Matter Hyperintensities in Stroke Patients: The Sydney Stroke Study Stroke, December 1, 2004; 35(12): 2813 - 2819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Wiseman, B. K. Saxby, E. J. Burton, R. Barber, G. A. Ford, and J. T. O'Brien Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects Neurology, November 23, 2004; 63(10): 1892 - 1897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Schmidt, Y. S. Aulchenko, N. Schweighofer, R. Schmidt, S. Frank, G. M. Kostner, E. Ott, and C. van Duijn Angiotensinogen Promoter B-Haplotype Associated With Cerebral Small Vessel Disease Enhances Basal Transcriptional Activity Stroke, November 1, 2004; 35(11): 2592 - 2597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shibata, T. Nabika, H. Moriyama, J. Masuda, and S. Kobayashi Correlation of NO Metabolites and 8-Iso-Prostaglandin F2a With Periventricular Hyperintensity Severity Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1659 - 1663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Wen, V. C.T. Mok, Y. H. Fan, W. W.M. Lam, W. K. Tang, A. Wong, R. X. Huang, and K. S. Wong Effect of White Matter Changes on Cognitive Impairment in Patients With Lacunar Infarcts Stroke, August 1, 2004; 35(8): 1826 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schmidt, Ph. Scheltens, T. Erkinjuntti, L. Pantoni, H. S. Markus, A. Wallin, F. Barkhof, and F. Fazekas White matter lesion progression: A surrogate endpoint for trials in cerebral small-vessel disease Neurology, July 13, 2004; 63(1): 139 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ihara, H. Tomimoto, K. Ishizu, T. Mukai, H. Yoshida, N. Sawamoto, M. Inoue, T. Doi, K. Hashikawa, J. Konishi, et al. Decrease in Cortical Benzodiazepine Receptors in Symptomatic Patients With Leukoaraiosis: A Positron Emission Tomography Study Stroke, April 1, 2004; 35(4): 942 - 947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Mezzapesa, M. A. Rocca, E. Pagani, G. Comi, and M. Filippi Evidence of Subtle Gray-Matter Pathologic Changes in Healthy Elderly Individuals With Nonspecific White-Matter Hyperintensities Arch Neurol, August 1, 2003; 60(8): 1109 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Inzitari Leukoaraiosis: An Independent Risk Factor for Stroke? Stroke, August 1, 2003; 34(8): 2067 - 2071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Streifler, M. Eliasziw, O. R. Benavente, S. Alamowitch, A. J. Fox, V. Hachinski, and H. J.M. Barnett Development and Progression of Leukoaraiosis in Patients With Brain Ischemia and Carotid Artery Disease Stroke, August 1, 2003; 34(8): 1913 - 1916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Pekala, A. C. Mamourian, H. A. Wishart, W. F. Hickey, and J. D. Raque Focal Lesion in the Splenium of the Corpus Callosum on FLAIR MR Images: A Common Finding with Aging and after Brain Radiation Therapy AJNR Am. J. Neuroradiol., May 1, 2003; 24(5): 855 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Ferguson, A. Blane, P. Perros, R. J. McCrimmon, J. J.K. Best, J. Wardlaw, I. J. Deary, and B. M. Frier Cognitive Ability and Brain Structure in Type 1 Diabetes: Relation to Microangiopathy and Preceding Severe Hypoglycemia Diabetes, January 1, 2003; 52(1): 149 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Pantoni, M. Simoni, G. Pracucci, R. Schmidt, F. Barkhof, and D. Inzitari Visual Rating Scales for Age-Related White Matter Changes (Leukoaraiosis): Can the Heterogeneity Be Reduced? Stroke, December 1, 2002; 33(12): 2827 - 2833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O.-C. Suter, T. Sunthorn, R. Kraftsik, J. Straubel, P. Darekar, K. Khalili, and J. Miklossy Cerebral Hypoperfusion Generates Cortical Watershed Microinfarcts in Alzheimer Disease Stroke, August 1, 2002; 33(8): 1986 - 1992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Y. Wong, R. Klein, A. R. Sharrett, D. J. Couper, B. E. K. Klein, D.-P. Liao, L. D. Hubbard, T. H. Mosley, and for the ARIC Investigators Cerebral White Matter Lesions, Retinopathy, and Incident Clinical Stroke JAMA, July 3, 2002; 288(1): 67 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J J Kril, S Patel, A J Harding, and G M Halliday Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss J. Neurol. Neurosurg. Psychiatry, June 1, 2002; 72(6): 747 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Streifler, M. Eliasziw, O. R. Benavente, S. Alamowitch, A. J. Fox, V. C. Hachinski, and H. J.M. Barnett Prognostic Importance of Leukoaraiosis in Patients With Symptomatic Internal Carotid Artery Stenosis Stroke, June 1, 2002; 33(6): 1651 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. I. Jennekens and L. Kater The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation Rheumatology, June 1, 2002; 41(6): 619 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Yamauchi, H Fukuda, and C Oyanagi Significance of white matter high intensity lesions as a predictor of stroke from arteriolosclerosis J. Neurol. Neurosurg. Psychiatry, May 1, 2002; 72(5): 576 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J.M. Barnett, H. E. Meldrum, and M. Eliasziw The appropriate use of carotid endarterectomy Can. Med. Assoc. J., April 1, 2002; 166(9): 1169 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-E. de Leeuw, J. C. de Groot, M. Oudkerk, J. C. M. Witteman, A. Hofman, J. van Gijn, and M. M. B. Breteler Hypertension and cerebral white matter lesions in a prospective cohort study Brain, March 1, 2002; 125(4): 765 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sierra, A. Coca, E. Gomez-Angelats, E. Poch, J. Sobrino, and A. de la Sierra Renin-Angiotensin System Genetic Polymorphisms and Cerebral White Matter Lesions in Essential Hypertension Hypertension, February 1, 2002; 39(2): 343 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Helenius, L. Soinne, O. Salonen, M. Kaste, and T. Tatlisumak Leukoaraiosis, Ischemic Stroke, and Normal White Matter on Diffusion-Weighted MRI Stroke, January 1, 2002; 33(1): 45 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F E Chukwudelunzu, J F Meschia, N R Graff-Radford, and J A Lucas Extensive metabolic and neuropsychological abnormalities associated with discrete infarction of the genu of the internal capsule J. Neurol. Neurosurg. Psychiatry, November 1, 2001; 71(5): 658 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schmidt, H. Schmidt, F. Fazekas, L. J. Launer, K. Niederkorn, P. Kapeller, A. Lechner, and G. M. Kostner Angiotensinogen Polymorphism M235T, Carotid Atherosclerosis, and Small-Vessel Disease-Related Cerebral Abnormalities Hypertension, July 1, 2001; 38(1): 110 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Schmidt, F. Fazekas, G. M. Kostner, C. M. van Duijn, and R. Schmidt Angiotensinogen Gene Promoter Haplotype and Microangiopathy-Related Cerebral Damage : Results of the Austrian Stroke Prevention Study Stroke, February 1, 2001; 32(2): 405 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sander, K. Winbeck, J. Klingelhofer, and B. Conrad Extent of Cerebral White Matter Lesions Is Related to Changes of Circadian Blood Pressure Rhythmicity Arch Neurol, September 1, 2000; 57(9): 1302 - 1307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Tullberg, J-E Mansson, P Fredman, A Lekman, K Blennow, R Ekman, L E Rosengren, M Tisell, and C Wikkelso CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy J. Neurol. Neurosurg. Psychiatry, July 1, 2000; 69(1): 74 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schmidt, H. Schmidt, F. Fazekas, P. Kapeller, G. Roob, A. Lechner, G. M. Kostner, and H.-P. Hartung MRI Cerebral White Matter Lesions and Paraoxonase PON1 Polymorphisms : Three-Year Follow-Up of the Austrian Stroke Prevention Study Arterioscler Thromb Vasc Biol, July 1, 2000; 20(7): 1811 - 1816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yamauchi, H. Fukuyama, and H. Shio Corpus Callosum Atrophy in Patients With Leukoaraiosis May Indicate Global Cognitive Impairment Stroke, July 1, 2000; 31(7): 1515 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-C. Lee, S.-J. Park, H.-K. Ki, H.-C. Gwon, C.-S. Chung, H. S. Byun, K.-J. Shin, M.-H. Shin, and W. R. Lee Prevalence and Risk Factors of Silent Cerebral Infarction in Apparently Normal Adults Hypertension, July 1, 2000; 36 (1): 73 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhu, L. Fratiglioni, Z. Guo, B. Winblad, and M. Viitanen Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project Neurology, June 13, 2000; 54(11): 2103 - 2107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Smith, D. A. Snowdon, H. Wang, and W. R. Markesbery White matter volumes and periventricular white matter hyperintensities in aging and dementia Neurology, February 22, 2000; 54(4): 838 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Del Bigio, H. J. Yan, P. Kozlowski, G. R. Sutherland, J. Peeling, and G. A. Rosenberg Serial Magnetic Resonance Imaging of Rat Brain After Induction of Renal Hypertension • Editorial Comment Stroke, November 1, 1999; 30(11): 2440 - 2447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Mantyla, H. J. Aronen, O. Salonen, T. Pohjasvaara, M. Korpelainen, T. Peltonen, C.-G. Standertskjold-Nordenstam, M. Kaste, and T. Erkinjuntti Magnetic Resonance Imaging White Matter Hyperintensities and Mechanism of Ischemic Stroke Stroke, October 1, 1999; 30(10): 2053 - 2058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Roman New Insight Into Binswanger Disease Arch Neurol, September 1, 1999; 56(9): 1061 - 1062. [Full Text] [PDF]
|
|
|
|
|
|
Z. Guo, L. Fratiglioni, L. Zhu, J. Fastbom, B. Winblad, and M. Viitanen Occurrence and Progression of Dementia in a Community Population Aged 75 Years and Older: Relationship of Antihypertensive Medication Use Arch Neurol, August 1, 1999; 56(8): 991 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schmidt, F. Fazekas, P. Kapeller, H. Schmidt, and H.-P. Hartung MRI white matter hyperintensities: Three-year follow-up of the Austrian Stroke Prevention Study Neurology, July 1, 1999; 53(1): 132 - 132. [Abstract] [Full Text]
|
|
|
|
|
|
M. Dichgans, M. Filippi, R. Bruning, G. Iannucci, C. Berchtenbreiter, L. Minicucci, I. Uttner, A. Crispin, H. Ludwig, T. Gasser, et al. Quantitative MRI in CADASIL: Correlation with disability and cognitive performance Neurology, April 1, 1999; 52(7): 1361 - 1361. [Abstract] [Full Text]
|
|
|
|
|
|
G. Roob, R. Schmidt, P. Kapeller, A. Lechner, H.-P. Hartung, and F. Fazekas MRI evidence of past cerebral microbleeds in a healthy elderly population Neurology, March 1, 1999; 52(5): 991 - 991. [Abstract] [Full Text]
|
|
|
|
|
|
L. Zhu, L. Fratiglioni, Z. Guo, H. Aguero-Torres, B. Winblad, and M. Viitanen Association of Stroke With Dementia, Cognitive Impairment, and Functional Disability in the Very Old : A Population-Based Study Stroke, October 1, 1998; 29(10): 2094 - 2099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nagaratnam and K. Nagaratnam Psychiatric and behavioral aspects of dementia of the Binswanger type American Journal of Alzheimer's Disease and Other Dementias, July 1, 1998; 13(4): 173 - 178. [Abstract] [PDF]
|
|
|
|
|
|
I. B. Goldstein, G. Bartzokis, D. B. Hance, and D. Shapiro Relationship Between Blood Pressure and Subcortical Lesions in Healthy Elderly People Stroke, April 1, 1998; 29(4): 765 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Kase, P. A. Wolf, M. Kelly-Hayes, W. B. Kannel, A. Beiser, and R. B. D'Agostino Intellectual Decline After Stroke : The Framingham Study Stroke, April 1, 1998; 29(4): 805 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Pantoni and D. Inzitari New Clinical Relevance of Leukoaraiosis Stroke, February 1, 1998; 29(2): 543 - 543. [Full Text] [PDF]
|
|
|
|
|
|
T. Adachi, M. Takagi, H. Hoshino, and T. Inafuku Effect of Extracranial Carotid Artery Stenosis and Other Risk Factors for Stroke on Periventricular Hyperintensity Stroke, November 1, 1997; 28(11): 2174 - 2179. [Abstract] [Full Text]
|
|
|
|
|
|
A. Chamorro, J. Pujol, A. Saiz, N. Vila, J. C. Vilanova, M. Alday, and R. Blanc Periventricular White Matter Lucencies in Patients With Lacunar Stroke: A Marker of Too High or Too Low Blood Pressure? Arch Neurol, October 1, 1997; 54(10): 1284 - 1288. [Abstract] [PDF]
|
|
|
|
|
|
R. Mantyla, T. Erkinjuntti, O. Salonen, H. J. Aronen, T. Peltonen, T. Pohjasvaara, and C.-G. Standertskjold-Nordenstam Variable Agreement Between Visual Rating Scales for White Matter Hyperintensities on MRI : Comparison of 13 Rating Scales in a Poststroke Cohort Stroke, August 1, 1997; 28(8): 1614 - 1623. [Abstract] [Full Text]
|
|
|
|
|
|
V. I. H. Kwa, J. Stam, L. M. Blok, B. Verbeeten Jr, and f. t. A. V. M. Group T2-Weighted Hyperintense MRI Lesions in the Pons in Patients With Atherosclerosis Stroke, July 1, 1997; 28(7): 1357 - 1360. [Abstract] [Full Text]
|
|
|
|
|
|
R. Schmidt, H. Schmidt, F. Fazekas, M. Schumacher, K. Niederkorn, P. Kapeller, V. Weinrauch, and G. M. Kostner Apolipoprotein E Polymorphism and Silent Microangiopathy-Related Cerebral Damage : Results of the Austrian Stroke Prevention Study Stroke, May 1, 1997; 28(5): 951 - 956. [Abstract] [Full Text]
|
|
|
|
|
|
L. Pantoni and J. H. Garcia Pathogenesis of Leukoaraiosis : A Review Stroke, March 1, 1997; 28(3): 652 - 659. [Abstract] [Full Text]
|
|
|
|
|
|
L. Pantoni, J. H. Garcia, J. A. Gutierrez, and W. I. Rosenblum Cerebral White Matter Is Highly Vulnerable to Ischemia Stroke, September 1, 1996; 27(9): 1641 - 1647. [Abstract] [Full Text]
|
|
|
|
|
|
G. C. Roman From UBOs to Binswanger's Disease: Impact of Magnetic Resonance Imaging on Vascular Dementia Research Stroke, August 1, 1996; 27(8): 1269 - 1273. [Full Text]
|
|
|
|
|
|
W.T. Longstreth, T. A. Manolio, A. Arnold, G. L. Burke, N. Bryan, C. A. Jungreis, P. L. Enright, D. O'Leary, and L. Fried Clinical Correlates of White Matter Findings on Cranial Magnetic Resonance Imaging of 3301 Elderly People: The Cardiovascular Health Study Stroke, August 1, 1996; 27(8): 1274 - 1282. [Abstract] [Full Text]
|
|
|
|
|
|
N. Watanabe, Y. Imai, K. Nagai, I. Tsuji, H. Satoh, M. Sakuma, H. Sakuma, J. Kato, N. Onodera-Kikuchi, M. Yamada, et al. Nocturnal Blood Pressure and Silent Cerebrovascular Lesions in Elderly Japanese Stroke, August 1, 1996; 27(8): 1319 - 1327. [Abstract] [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||